$3.1 Billion is the total value of BRAIDWELL LP's 70 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCnote11/1 | $183,591,669 | -2.9% | 268,252,000 | 0.0% | 5.92% | -14.8% | ||
Buy | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $146,211,682 | +5.6% | 135,838,000 | +18.8% | 4.71% | -7.3% | |
Buy | EXACT SCIENCES CORPnote 0.375% 3/0 | $133,113,600 | +8.1% | 144,000,000 | +9.9% | 4.29% | -5.2% | |
NOVOCURE LTDnote11/0 | $124,627,695 | +5.7% | 135,834,000 | 0.0% | 4.02% | -7.3% | ||
Buy | APOGEE THERAPEUTICS INC | $122,435,122 | +543.4% | 1,842,515 | +170.5% | 3.95% | +464.5% | |
Buy | NUVASIVE INCnote 0.375% 3/1 | $109,038,179 | +46.8% | 114,206,000 | +41.8% | 3.51% | +28.8% | |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $100,710,425 | +6.9% | 730,209 | +2.1% | 3.25% | -6.2% |
ARGX | Buy | ARGENX SEsponsored adr | $86,549,105 | +48.5% | 219,824 | +43.5% | 2.79% | +30.3% |
PCVX | Sell | VAXCYTE INC | $82,839,742 | +2.3% | 1,212,703 | -6.0% | 2.67% | -10.3% |
Buy | NEOGENOMICS INCnote 0.250% 1/1 | $82,605,050 | +64.6% | 103,580,000 | +57.9% | 2.66% | +44.4% | |
Buy | DEXCOM INCnote 0.250%11/1 | $71,589,769 | +51.7% | 65,000,000 | +44.4% | 2.31% | +33.0% | |
LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $69,764,462 | +106.1% | 1,243,795 | +121.1% | 2.25% | +80.9% |
Buy | INSMED INCnote 1.750% 1/1 | $69,429,090 | +23.7% | 64,887,000 | +23.9% | 2.24% | +8.6% | |
Buy | INSULET CORPnote 0.375% 9/0 | $68,854,500 | -5.3% | 66,000,000 | +4.8% | 2.22% | -16.9% | |
PEN | Buy | PENUMBRA INC | $66,037,177 | +17.8% | 295,892 | +32.8% | 2.13% | +3.4% |
MRVI | Buy | MARAVAI LIFESCIENCES HLDGS I | $62,614,393 | +89.6% | 7,221,960 | +43.3% | 2.02% | +66.4% |
SAREPTA THERAPEUTICS INCnote 1.250% 9/1 | $59,309,620 | +15.1% | 50,666,000 | 0.0% | 1.91% | +1.1% | ||
VKTX | New | VIKING THERAPEUTICS INC | $58,474,200 | – | 713,100 | +100.0% | 1.88% | – |
XENE | Sell | XENON PHARMACEUTICALS INC | $56,309,874 | -25.8% | 1,308,011 | -20.6% | 1.82% | -34.9% |
IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $56,057,812 | -7.8% | 483,257 | -14.9% | 1.81% | -19.1% |
ALGN | Buy | ALIGN TECHNOLOGY INC | $55,501,116 | +38.4% | 169,252 | +15.7% | 1.79% | +21.5% |
BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $55,137,279 | -3.8% | 67,294,000 | 0.0% | 1.78% | -15.6% | ||
Buy | IRONWOOD PHARMACEUTICALS INCnote 1.500% 6/1 | $53,701,147 | +218.3% | 52,740,000 | +240.3% | 1.73% | +179.2% | |
GH | Buy | GUARDANT HEALTH INC | $51,096,467 | +148.9% | 2,476,804 | +226.4% | 1.65% | +118.4% |
TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $49,645,727 | +4.1% | 56,031,000 | 0.0% | 1.60% | -8.7% | ||
New | CG ONCOLOGY INC | $49,617,317 | – | 1,130,235 | +100.0% | 1.60% | – | |
KROS | Sell | KEROS THERAPEUTICS INC | $48,814,490 | +9.7% | 737,379 | -34.1% | 1.57% | -3.7% |
TMDX | Buy | TRANSMEDICS GROUP INC | $45,438,422 | +389.1% | 614,531 | +422.1% | 1.46% | +329.3% |
AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $45,071,793 | – | 2,668,549 | +100.0% | 1.45% | – |
GKOS | Buy | GLAUKOS CORP | $42,494,240 | +120.2% | 450,676 | +85.6% | 1.37% | +93.2% |
Buy | PARAGON 28 INC | $41,565,271 | -0.5% | 3,365,609 | +0.1% | 1.34% | -12.7% | |
ISRG | New | INTUITIVE SURGICAL INC | $40,108,545 | – | 100,500 | +100.0% | 1.29% | – |
DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $35,909,590 | -41.7% | 2,173,704 | -48.4% | 1.16% | -48.8% |
KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $35,793,199 | +8.5% | 65,976,000 | 0.0% | 1.15% | -4.8% | ||
Buy | ALPHATEC HLDGS INCnote 0.750% 8/0 | $33,852,988 | +19.3% | 32,434,000 | +21.2% | 1.09% | +4.7% | |
FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $33,532,172 | – | 1,052,485 | +100.0% | 1.08% | – |
KIDS | ORTHOPEDIATRICS CORP | $32,302,573 | -10.3% | 1,107,770 | 0.0% | 1.04% | -21.3% | |
KRYS | Sell | KRYSTAL BIOTECH INC | $31,509,446 | +29.5% | 177,089 | -9.7% | 1.02% | +13.6% |
RLAY | New | RELAY THERAPEUTICS INC | $31,075,192 | – | 3,743,999 | +100.0% | 1.00% | – |
IRWD | New | IRONWOOD PHARMACEUTICALS INC | $30,396,533 | – | 3,489,843 | +100.0% | 0.98% | – |
KNSA | New | KINIKSA PHARMACEUTICALS LTD | $27,478,287 | – | 1,392,716 | +100.0% | 0.89% | – |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $27,403,470 | -31.8% | 47,149 | -37.8% | 0.88% | -40.2% |
RGEN | Buy | REPLIGEN CORP | $26,270,397 | +42.3% | 142,836 | +39.1% | 0.85% | +24.9% |
NVRO | NEVRO CORP | $25,650,754 | -32.9% | 1,776,368 | 0.0% | 0.83% | -41.1% | |
INSP | Sell | INSPIRE MED SYS INC | $21,799,467 | -42.0% | 101,492 | -45.0% | 0.70% | -49.1% |
CGEM | CULLINAN ONCOLOGY INC | $21,144,340 | +67.2% | 1,240,865 | 0.0% | 0.68% | +46.8% | |
TOURMALINE BIO INC | $20,766,178 | -12.5% | 906,820 | 0.0% | 0.67% | -23.3% | ||
New | LEXEO THERAPEUTICS INC | $20,733,303 | – | 1,322,277 | +100.0% | 0.67% | – | |
Sell | IRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1 | $19,937,500 | -49.5% | 20,000,000 | -46.7% | 0.64% | -55.7% | |
New | HAEMONETICS CORP MASSnote3/0 | $19,846,650 | – | 21,500,000 | +100.0% | 0.64% | – | |
SPYRE THERAPEUTICS INC | $19,533,950 | +76.3% | 515,000 | 0.0% | 0.63% | +54.8% | ||
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $19,118,377 | – | 218,896 | +100.0% | 0.62% | – |
Buy | STRUCTURE THERAPEUTICS INCsponsored ads | $18,679,374 | +63.6% | 435,823 | +55.6% | 0.60% | +43.7% | |
BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $17,168,251 | -49.9% | 3,379,577 | -40.9% | 0.55% | -56.0% |
ITOS | New | ITEOS THERAPEUTICS INC | $15,854,781 | – | 1,162,374 | +100.0% | 0.51% | – |
Sell | MINERALYS THERAPEUTICS INC | $14,809,758 | -14.9% | 1,147,154 | -43.3% | 0.48% | -25.4% | |
ALEC | Sell | ALECTOR INC | $14,331,838 | -46.0% | 2,380,704 | -28.4% | 0.46% | -52.6% |
ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $12,883,000 | – | 1,300,000 | +100.0% | 0.42% | – |
ELEV | New | ELEVATION ONCOLOGY INC | $12,197,329 | – | 2,377,647 | +100.0% | 0.39% | – |
BBIO | New | BRIDGEBIO PHARMA INC | $10,662,051 | – | 344,827 | +100.0% | 0.34% | – |
IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $9,781,526 | – | 660,022 | +100.0% | 0.32% | – |
DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $9,589,684 | -49.2% | 609,643 | -47.9% | 0.31% | -55.4% |
OLMA | New | OLEMA PHARMACEUTICALS INC | $7,973,174 | – | 704,344 | +100.0% | 0.26% | – |
LUNG | Sell | PULMONX CORP | $6,976,055 | -30.6% | 752,541 | -4.5% | 0.22% | -39.0% |
CUTERA INCnote 4.000% 6/0 | $6,435,138 | -1.7% | 29,000,000 | 0.0% | 0.21% | -13.8% | ||
DBVT | DBV TECHNOLOGIES S Asponsored adr | $5,927,170 | -20.7% | 7,843,285 | 0.0% | 0.19% | -30.3% | |
Sell | CUTERA INCnote 2.250% 6/0 | $5,742,132 | -31.4% | 25,240,000 | -20.9% | 0.18% | -39.9% | |
OM | OUTSET MED INC | $5,328,948 | -59.0% | 2,400,427 | 0.0% | 0.17% | -63.9% | |
ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4,357,543 | -34.5% | 1,357,490 | 0.0% | 0.14% | -42.6% | |
HROW | Sell | HARROW INC | $1,666,543 | -90.1% | 125,967 | -91.6% | 0.05% | -91.2% |
CMPX | Exit | COMPASS THERAPEUTICS INC | $0 | – | -317,761 | -100.0% | -0.02% | – |
Exit | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $0 | – | -3,650,000 | -100.0% | -0.10% | – | |
Exit | HILLEVAX INC | $0 | – | -203,407 | -100.0% | -0.12% | – | |
Exit | IONIS PHARMACEUTICALS INCnote 4/0 | $0 | – | -5,240,000 | -100.0% | -0.20% | – | |
VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -323,102 | -100.0% | -0.26% | – |
Exit | NEOGENOMICS INCnote 1.250% 5/0 | $0 | – | -10,000,000 | -100.0% | -0.34% | – | |
RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -389,300 | -100.0% | -0.36% | – |
DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -461,769 | -100.0% | -0.36% | – |
DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -755,811 | -100.0% | -0.37% | – |
MRUS | Exit | MERUS N V | $0 | – | -370,679 | -100.0% | -0.37% | – |
Exit | TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $0 | – | -16,850,000 | -100.0% | -0.41% | – | |
Exit | THIRD HARMONIC BIO INC | $0 | – | -1,316,018 | -100.0% | -0.53% | – | |
Exit | INVITAE CORPnote 2.000% 9/0 | $0 | – | -16,781,000 | -100.0% | -0.54% | – | |
TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -2,318,050 | -100.0% | -0.55% | – |
AMGN | Exit | AMGEN INC | $0 | – | -58,200 | -100.0% | -0.62% | – |
LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -495,100 | -100.0% | -1.13% | – |
IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -611,365 | -100.0% | -1.53% | – |
Exit | TANDEM DIABETES CARE INCnote 1.500% 5/0 | $0 | – | -71,051,000 | -100.0% | -2.47% | – | |
Exit | ASCENDIS PHARMA A/Snote 2.250% 4/0 | $0 | – | -126,897,000 | -100.0% | -4.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GUARDANT HEALTH INC | 7 | Q2 2024 | 6.9% |
NOVOCURE LTD | 7 | Q2 2024 | 4.3% |
BRIDGEBIO PHARMA INC | 7 | Q2 2024 | 5.1% |
XENON PHARMACEUTICALS INC | 7 | Q2 2024 | 3.1% |
VAXCYTE INC | 7 | Q2 2024 | 3.0% |
NUVASIVE INC | 7 | Q2 2024 | 3.5% |
ALPHATEC HLDGS INC | 7 | Q2 2024 | 3.6% |
GLAUKOS CORP | 7 | Q2 2024 | 3.0% |
ALIGN TECHNOLOGY INC | 7 | Q2 2024 | 2.6% |
IRHYTHM TECHNOLOGIES INC | 7 | Q2 2024 | 2.2% |
View BRAIDWELL LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.